✦ LIBER ✦

Switching to adalimumab for psoriasis patients with a suboptimal response to etanercept, methotrexate, or phototherapy: Efficacy and safety results from an open-label study

✍ Scribed by Bruce E. Strober; Yves Poulin; Francisco A. Kerdel; Richard G. Langley; Yihua Gu; Shiraz R. Gupta; Martin M. Okun; Kim A. Papp

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Transitioning psoriasis patients to adal

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Adalimumab treatment of psoriasis patien

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Efficacy, safety and medication cost imp

✍ C. Leonardi; J.M. Sobell; J.J. Crowley; U. Mrowietz; Y. Bao; P.M. Mulani; Y. Gu; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 877 KB

The efficacy and safety of infliximab in

✍ Gottlieb, Alice B.; Kalb, Robert E.; Blauvelt, Andrew; Heffernan, Michael P.; So 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 430 KB

Efficacy and safety of briakinumab for t

📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Long-term efficacy and safety of adalimu

✍ Kenneth Gordon; Kim Papp; Yves Poulin; Yihua Gu; Stephen Rozzo; Eric H. Sasso 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 347 KB